Skip to main content
. Author manuscript; available in PMC: 2015 Mar 4.
Published in final edited form as: Mol Biosyst. 2014 Jan 9;10(3):581–591. doi: 10.1039/c3mb70503j

Table 3.

Top FDA-Approved Drugs Identified using Erlotinib Binding Profile

Name Indication (DrugBank)
Ergotamine Migraine headaches
Treprostinil Pulmonary Arterial Hypertension
Bexarotene Cutaneous T-cell lymphoma
Astemizole Seasonal allergic rhinitis
Podofilox External genital warts (Condyloma acuminatum)
Forasartan Hypertension
Acenocoumarol Thromboembolic diseases
Desoxycorticoserone
Pivalate
Adrenocortical insufficiency
Dihydroergotamine Migraine headaches
Latanoprost Glaucoma or occular hypertension
Lapatinib Advanced or metastatic breast cancer
Dasatinib Chronic, accelerated, or myeloid or lymphoid blast phase chronic
myeloid leukemia